Literature DB >> 20347640

Genetic basis of nondiabetic end-stage renal disease.

Barry I Freedman1, Rulan S Parekh, W H Linda Kao.   

Abstract

Recent breakthroughs in genomics have led to a critical reappraisal of factors once thought to initiate common complex forms of kidney disease. The tenet that diabetes mellitus and hypertension routinely initiate kidney disease whenever blood glucose concentrations or systemic blood pressures reach critical levels for prolonged periods is falling from favor, although it remains important to control hypertension and hyperglycemia to slow nephropathy progression and to prevent cardiovascular disease. Many patients with systemic diseases that potentially may involve their kidneys never develop nephropathy. In addition, severe forms of several common kidney diseases cluster tightly in families. This article discusses the existence of differential nephropathy susceptibility based on an individual's genetic make-up, in the context of environmental exposures. Novel genetic analysis methods and recently identified major kidney disease susceptibility genes are discussed, including novel perspectives for categorizing complex forms of nephropathy based on the expanding spectrum of non-muscle myosin heavy chain 9 gene-associated disease. Genetic screening, gene-environment, and gene-gene interactions are also addressed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347640      PMCID: PMC2909624          DOI: 10.1016/j.semnephrol.2010.01.002

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  50 in total

1.  MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.

Authors:  Jeffrey B Kopp; Michael W Smith; George W Nelson; Randall C Johnson; Barry I Freedman; Donald W Bowden; Taras Oleksyk; Louise M McKenzie; Hiroshi Kajiyama; Tejinder S Ahuja; Jeffrey S Berns; William Briggs; Monique E Cho; Richard A Dart; Paul L Kimmel; Stephen M Korbet; Donna M Michel; Michele H Mokrzycki; Jeffrey R Schelling; Eric Simon; Howard Trachtman; David Vlahov; Cheryl A Winkler
Journal:  Nat Genet       Date:  2008-09-14       Impact factor: 38.330

2.  Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD.

Authors:  Barry I Freedman; Pamela J Hicks; Meredith A Bostrom; Mary E Comeau; Jasmin Divers; Anthony J Bleyer; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; Carl D Langefeld; Donald W Bowden
Journal:  Nephrol Dial Transplant       Date:  2009-06-30       Impact factor: 5.992

3.  Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.

Authors:  Barry I Freedman; Pamela J Hicks; Meredith A Bostrom; Mary E Cunningham; Yongmei Liu; Jasmin Divers; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; Carl D Langefeld; Donald W Bowden
Journal:  Kidney Int       Date:  2009-01-28       Impact factor: 10.612

4.  Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expression.

Authors:  Natalia Papeta; Ka-Tak Chan; Sindhuri Prakash; Jeremiah Martino; Krzysztof Kiryluk; David Ballard; Leslie A Bruggeman; Rachelle Frankel; Zongyu Zheng; Paul E Klotman; Hongyu Zhao; Vivette D D'Agati; Richard P Lifton; Ali G Gharavi
Journal:  J Clin Invest       Date:  2009-04-20       Impact factor: 14.808

5.  Genome-wide linkage analysis of serum creatinine in three isolated European populations.

Authors:  Cristian Pattaro; Yurii S Aulchenko; Aaron Isaacs; Veronique Vitart; Caroline Hayward; Christopher S Franklin; Ozren Polasek; Ivana Kolcic; Zrinka Biloglav; Susan Campbell; Nick Hastie; Gordan Lauc; Thomas Meitinger; Ben A Oostra; Ulf Gyllensten; James F Wilson; Irene Pichler; Andrew A Hicks; Harry Campbell; Alan F Wright; Igor Rudan; Cornelia M van Duijn; Peter Riegler; Fabio Marroni; Peter P Pramstaller
Journal:  Kidney Int       Date:  2009-04-22       Impact factor: 10.612

Review 6.  Progression of glomerular and tubular disease in pediatrics.

Authors:  Robert P Woroniecki; H William Schnaper
Journal:  Semin Nephrol       Date:  2009-07       Impact factor: 5.299

7.  MYH9 is associated with nondiabetic end-stage renal disease in African Americans.

Authors:  W H Linda Kao; Michael J Klag; Lucy A Meoni; David Reich; Yvette Berthier-Schaad; Man Li; Josef Coresh; Nick Patterson; Arti Tandon; Neil R Powe; Nancy E Fink; John H Sadler; Matthew R Weir; Hanna E Abboud; Sharon G Adler; Jasmin Divers; Sudha K Iyengar; Barry I Freedman; Paul L Kimmel; William C Knowler; Orly F Kohn; Kristopher Kramp; David J Leehey; Susanne B Nicholas; Madeleine V Pahl; Jeffrey R Schelling; John R Sedor; Denyse Thornley-Brown; Cheryl A Winkler; Michael W Smith; Rulan S Parekh
Journal:  Nat Genet       Date:  2008-09-14       Impact factor: 38.330

8.  Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study.

Authors:  Barry I Freedman; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; D C Rao; John H Eckfeldt; Mark F Leppert; Pamela J Hicks; Jasmin Divers; Carl D Langefeld; Steven C Hunt
Journal:  Am J Nephrol       Date:  2009-01-20       Impact factor: 3.754

9.  Chromogranin A regulates renal function by triggering Weibel-Palade body exocytosis.

Authors:  Yuqing Chen; Manjula Mahata; Fangwen Rao; Srikrishna Khandrika; Maite Courel; Maple M Fung; Kuixing Zhang; Mats Stridsberg; Michael G Ziegler; Bruce A Hamilton; Michael S Lipkowitz; Laurent Taupenot; Caroline Nievergelt; Sushil K Mahata; Daniel T O'Connor
Journal:  J Am Soc Nephrol       Date:  2009-06-11       Impact factor: 10.121

10.  Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy.

Authors:  Marcus G Pezzolesi; Pisut Katavetin; Masahiko Kure; G David Poznik; Jan Skupien; Josyf C Mychaleckyj; Stephen S Rich; James H Warram; Andrzej S Krolewski
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

View more
  7 in total

1.  Poverty and racial disparities in kidney disease: the REGARDS study.

Authors:  William M McClellan; Britt B Newsome; Leslie A McClure; George Howard; Nataliya Volkova; Paul Audhya; David G Warnock
Journal:  Am J Nephrol       Date:  2010-05-31       Impact factor: 3.754

Review 2.  Arrest of the true culprit and acquittal of the innocent? Genetic revelations charge APOL1 variants with kidney disease susceptibility.

Authors:  Martin Zenker; Peter R Mertens
Journal:  Int Urol Nephrol       Date:  2010-11-16       Impact factor: 2.370

3.  Past Decline Versus Current eGFR and Subsequent ESRD Risk.

Authors:  Csaba P Kovesdy; Josef Coresh; Shoshana H Ballew; Mark Woodward; Adeera Levin; David M J Naimark; Joseph Nally; Dietrich Rothenbacher; Benedicte Stengel; Kunitoshi Iseki; Kunihiro Matsushita; Andrew S Levey
Journal:  J Am Soc Nephrol       Date:  2015-12-11       Impact factor: 10.121

4.  Association of coronary artery disease and chronic kidney disease in Lebanese population.

Authors:  Aline Milane; Georges Khazen; Nabil Zeineddine; Mazen Amro; Leila Masri; Michella Ghassibe-Sabbagh; Sonia Youhanna; Angelique K Salloum; Marc Haber; Daniel E Platt; Jean-Baptiste Cazier; Raed Othman; Samer Kabbani; Hana Sbeite; Youssef Chami; Elie Chammas; Hamid El Bayeh; Dominique Gauguier; Antoine B Abchee; Pierre Zalloua; Antoine Barbari
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  Risk Adjustment and the Assessment of Disparities in Dialysis Mortality Outcomes.

Authors:  John Kalbfleisch; Robert Wolfe; Sarah Bell; Rena Sun; Joseph Messana; Tempie Shearon; Valarie Ashby; Robin Padilla; Min Zhang; Marc Turenne; Jeffrey Pearson; Claudia Dahlerus; Yi Li
Journal:  J Am Soc Nephrol       Date:  2015-04-16       Impact factor: 10.121

6.  Survival advantage in black versus white men with CKD: effect of estimated GFR and case mix.

Authors:  Csaba P Kovesdy; L Darryl Quarles; Evan H Lott; Jun Ling Lu; Jennie Z Ma; Miklos Z Molnar; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2013-01-29       Impact factor: 8.860

7.  Non-diabetic end-stage renal disease in Saudis associated with polymorphism of MYH9 gene but not UMOD gene.

Authors:  Khalid Mohamed Adam; Ali Mahmoud Mohammed; Abubakr Ali Elamin
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.